Crysvita
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Crysvita, covering 2018-04-17 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Crysvita (burosumab) — Kyowa Kirin Holdings B.V.
13 regulatory and trial events tracked for Crysvita, covering 2018-04-17 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Crysvita (burosumab) — Kyowa Kirin Holdings B.V.